353 related articles for article (PubMed ID: 29085212)
21. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
[TBL] [Abstract][Full Text] [Related]
22. Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
Zeng Z; Liao X; Huang K; Han C; Qin W; Su H; Ye X; Yang C; Zhou X; Wei Y; Mo S; Liu J; Lan C; Huang X; Huang Z; Peng K; Gao Q; Peng T; Zhu G
World J Surg Oncol; 2023 Oct; 21(1):322. PubMed ID: 37833735
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
24. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
25. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients.
Pontisso P; Belluco C; Bertorelle R; De Moliner L; Chieco-Bianchi L; Nitti D; Lise M; Alberti A
Cancer; 1998 Oct; 83(8):1489-94. PubMed ID: 9781942
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
Li G; Zheng Z
Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
[TBL] [Abstract][Full Text] [Related]
28. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
29. Tumor Necrosis Factor Alpha 308 G/A Single Nucleotide Polymorphism and Susceptibility to Hepatocellular Carcinoma Via Hepatitis B Infection.
Azar SS; Mansoori M; Attar M; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(7):3381-4. PubMed ID: 27509979
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S
Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406
[TBL] [Abstract][Full Text] [Related]
31. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
[TBL] [Abstract][Full Text] [Related]
33. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.
Liu Y; Sui J; Zhai L; Yang S; Huang L; Huang L; Mo C; Wu J; Li S; Qin X
Med Oncol; 2014 Oct; 31(10):200. PubMed ID: 25195037
[TBL] [Abstract][Full Text] [Related]
35. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
36. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
37. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
38. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
39. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.
Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):64-71. PubMed ID: 15017634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
